News
-
-
-
-
REGULATED PRESS RELEASE
PR – ICADE – Standard & Poor’s downgrades the outlook on Icade’s long-term credit rating (BBB+) from stable to negative and revises the Group’s target ratios
S&P Global downgrades Icade's long-term credit rating outlook from stable to negative and revises financial ratio thresholds. Icade reaffirms commitment to financial policy -
REGULATED PRESS RELEASE
CP – ICADE – Standard & Poor’s abaisse la perspective de la notation de crédit long terme BBB+ d’Icade de stable à négative et précise les ratios cibles du Groupe
Standard & Poor's abaisse la perspective de notation de crédit d'Icade de BBB+ à négative, ajustant les ratios financiers et objectifs du groupe immobilier -
-
-
-
PRESS RELEASE
DEAG fully on track with very good organic business development in 2023 – Detlef Kornett named sole CEO of DEAG
DEAG reports strong financial performance in 2023; Detlef Kornett named sole CEO. Revenue approx. EUR 313 million. EBITDA approx. EUR 31 million. Buy-and-build strategy successful -
PRESS RELEASE
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap, with a target price of €3.20 and a potential upside of 87% according to the study 'Du baume au coeur'. The coverage adds to the financial analyst consensus
